Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) remain major causes of heart failure, stroke and death among African women and children, despite being preventable and imminently treatable. From 21 to 22 February 2015, the Social Cluster of the Africa Union Commission (AUC) hosted a consultation with RHD experts convened by the Pan-African Society of Cardiology (PASCAR) in Addis Ababa, Ethiopia, to develop a 'roadmap' of key actions that need to be taken by governments to eliminate ARF and eradicate RHD in Africa.
the reduction of mortality by 25% by the year 2025, (2) ensure an adequate supply of high-quality benzathine penicillin for the primary and secondary prevention of ARF/RHD, (3) improve access to reproductive health services for women with RHD and other non-communicable diseases (NCD), (4) decentralise technical expertise and technology for diagnosing and managing ARF and RHD (including ultrasound of the heart), (5) establish national and regional centres of excellence for essential cardiac surgery for the treatment of affected patients and training of cardiovascular practitioners of the future, (6) initiate national multi-sectoral RHD programmes within NCD control programmes of affected countries, and (7) foster international partnerships with multinational organsations for resource mobilisation, monitoring and evaluation of the programme to end RHD in Africa.
This Addis Ababa communiqué has since been endorsed by African Union heads of state, and plans are underway to implement the roadmap in order to end ARF and RHD in Africa in our lifetime.
Keywords: rheumatic heart disease, prevention While acute rheumatic fever (ARF) essentially vanished from industrialised countries during the latter half of the 20th century, 1 the condition and its major sequel, rheumatic heart disease (RHD) remain important public health concerns in Africa. Poverty and inadequate primary healthcare systems are major contributors to the persistence of ARF/RHD in Africa. 2 On the other hand, improving economic conditions and enhanced health system investments during the HIV/AIDS era offer an opportunity to address this neglected disease of poverty in a co-ordinated fashion. 3, 4 Over the past decade, there has been a renewed global interest in RHD as well as a proliferation of scientific and public health work led by African investigators and practitioners. 5 At the same time, the World Heart Federation (WHF) non-communicable disease action plan, developed for the World Health Assembly in 2013, called for a 25% reduction in premature mortality from RHD by the year 2025 ('25 by 25').
From 21 to 22 February 2015, the Social Cluster of the African Union Commission (AUC) hosted the Third All-Africa Workshop on ARF and RHD, which was an expert consultation of RHD clinicians and researchers affiliated with the Pan-African Society of Cardiology (PASCAR). This meeting was intended to develop a roadmap that could be adopted by ministries of health and governments in order to eliminate ARF and control RHD in their home countries. This article outlines the Addis Ababa communiqué that emerged from the consultative meeting, and also provides a brief report of the objectives and proceedings of the meeting, as well as the outcomes of the meeting in the first six months thereafter.
the addis ababa communiqué on eradication of rhd in africa
Motivation
The communiqué began by recalling that RHD is both preventable and common in Africa, affecting 1.5 to 3% of school-aged children. 10, 11 Because severe RHD is lethal in the absence of surgical treatment, 12 the total economic cost of premature mortality in Africa is staggering, 13 and hampers the achievement of the Millennium Development Goals and forthcoming Sustainable Development Goals on health. The problem has been made worse by a lack of comprehensive, integrated prevention and control programmes in most African Union (AU) member states that carry a heavy burden of ARF/RHD.
The AU recognised several mandates to convene this meeting and discuss a roadmap for ARF/RHD in Africa. These included the following: 
Barriers to action
The foundation of the recommendations of the communiqué was a recent publication of baseline characteristics of patients with RHD from 12 African countries. 9 Several of the key barriers to control of RHD in Africa are listed in Table 1 . Notably, despite the lack of progress on RHD control in Africa, there are several examples of countries, such as Cuba, 14 Costa Rica, 15 and Tunisia, 16 that have realised the eradication of ARF and control of RHD over several years by implementing co-ordinated and comprehensive public health programmes.
Meeting objectives and proceedings
The objectives of the Third All-Africa Workshop on ARF and RHD were as follows:
• develop approaches on how to eradicate RHD in Africa • develop milestones for the eradication of RHD Three main activities comprised the meeting: • Formal presentations on successful ARF/RHD control programmes in Africa and Oceania.
• Breakout sessions on the minimal datasets that are needed, key investments that will be required, and stakeholder participation that should be sought in order to develop ARF/RHD programmes in African countries.
• A group deliberation on the final set of expert recommendations and key principles to be enumerated in the communiqué. At the close of the meeting, the principles of the communiqué, reproduced in Table 2 , were assented to, and the document was sent by the AUC to the April 2015 Ministerial Conference on Health, Population and Drug Control for consideration.
Recommendations
1. Establish prospective RHD registers. These would occur at sentinel sites in AU member states affected by ARF/RHD. The major objective of these registers will be to monitor progress towards RHD-related health outcomes, which include a 25% reduction in premature mortality from RHD by the year 2025.
Ensure adequate supplies of benzathine penicillin G (BPG).
The WHO recognises BPG as an essential medication. In order to achieve adequate coverage of primary and secondary prevention measures for ARF/RHD, BPG must be readily available at all primary care facilities in AU member states, and training of providers on effective and safe use of BPG should be part of supply-side efforts. BPG can also be used for the treatment of other endemic diseases in Africa, such as syphilis, yaws and sickle cell disease. 3. Guarantee universal access to reproductive health services for women with RHD. RHD greatly increases a woman's risk of mortality and foetal demise during pregnancy. Reproductive health services, including contraception, are currently underutilised among women with RHD in Africa and this contributes to the high maternal mortality rates on the continent. Comprehensive care for RHD and other NCDs should include access to reproductive health services for all women at risk. 4. Decentralise diagnostic services for ARF/RHD to district hospitals. Primary healthcare services and district hospitals need appropriate technical expertise in the diagnosis of ARF and RHD. Key point-of-care technologies that should be considered for provision at district and community levels include ultrasound of the heart (echocardiography), anticoagulation testing, and antigen tests for the rapid diagnosis of group A streptococcal pharyngitis. 5. Establish cardiac surgery centres of excellence. Such facilities could sustainably deliver state-of-the-art surgical care as well as train the next generation of African cardiac specialists. They could also be centres of research on endemic cardiovascular diseases (including RHD). 6. Foster multi-sectoral and integrated national RHD control programmes led by ministries responsible for health. These programmes would oversee the implementation of national RHD action plans and progress towards the '25-by-25' targets. 7. Cultivate partnerships that can implement the actions above.
A partnership needs to be developed between the AU commission, ministries responsible for health, international agencies, governments, industry, academia, civil society and other relevant stakeholder to monitor and evaluate progress related to the implementation of the key actions and achievement of the outcome of 25% reduction in premature mortality from RHD by the year 2025. In addition to these recommendations, important and specific roles for international stakeholders (Table 3) were identified. Finally, the communiqué requested the AU to mandate PASCAR and other stakeholders to work with the AU commission to develop a detailed implementation plan of the key actions. This would include roles and responsibilities, timelines, estimates of costs, and a communication framework for the roadmap. 2. Ensure adequate supplies of high-quality benzathine penicillin that can be administered in the most effective manner, in order to achieve primary and secondary prevention of RHD.
Adoption and next steps
3. Guarantee universal access to reproductive health services for women with RHD and other NCDs, in whom pregnancy carries specific and often fatal risks, and for whom contraception can reduce maternal and foetal mortality.
4. Decentralise appropriate technical expertise to the primary and district levels in order to improve the diagnosis of ARF (which is under-diagnosed in Africa) and early detection, diagnosis, secondary prevention and treatment of RHD using cross-cutting point-of-care technologies such as cardiac ultrasound, anticoagulation testing and rapid antigen tests for group A streptococcal pharyngitis.
5. Establish centres of excellence for cardiac surgery, which will sustainably deliver state-of-the-art surgical care, train the next generation of African cardiac practitioners, and conduct research on endemic cardiovascular diseases, including RHD.
6. Foster multi-sectoral and integrated national RHD control programmes led by the Ministry of Health, which will oversee the implementation of national RHD action plans in order to achieve the goal of reducing mortality from RHD and other NCDs by 25% by the year 2015.
7. Cultivate, through a strong communication framework, partnerships between the AUC, ministries responsible for health, international agencies, governments, industry, academia, civil society and other relevant stakeholders, in order to ensure the implementation of the above actions, and the connection of African RHD control measures with the emerging global movement towards RHD control.
of health, population and drug control) where it was adopted unanimously and referred for further consideration to the African Union Heads and Government Summit. 17 In their meeting held from 7 to 12 June 2015 in Johannesburg, South Africa, the 27th ordinary session of the Executive Council (Ministers of Foreign Affairs) adopted the document under declaration number EX.CL/Dec.876(XXVII), and it was endorsed by the 25th AU Heads of State and Government Summit that was held from 14 to 15 June 2015 in Johannesburg, South Africa.
Following on the formal adoption of the principles of the expert consultation, it is now incumbent on ministries of health of AU member states to develop local implementation plans. The PASCAR ARF/RHD task force is developing principles for implementation of ARF/RHD action plans at the local level, which will include an analysis of the key financial and human resource investments required in order to accomplish the objectives of the Addis Ababa communiqué. To this end, PASCAR and the AUC plan to convene a workshop in March 2016 on the implementation of the Addis Ababa communiqué at country level.
Conclusions
Over the past 25 years, ARF and RHD have endured on the African continent despite dramatic progress in the control of many other important childhood, adolescent and maternal conditions. [18] [19] [20] The partnership between the African Union Commission and the Pan-African Society of Cardiology, and the subsequent political commitment to the principles for the eradication of ARF/RHD in Africa, promises to change this situation. It is hoped that the implementation of action plans on ARF/RHD will, through a concerted and multi-sectoral effort, rapidly improve cardiovascular health and strengthen health systems for chronic non-communicable diseases in Africa.
